Oxaflumazine
- Level
- Commodity
- Parent
- 51332800
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51332813This classification denotes an antipsychotic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0ME957NZRY. European Medicines Agency schedules Oxaflumazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09487MIG. Oxaflumazine generally arises in the molecular formula C26H32F3N3O2S. The term OXAFLUMAZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 no. 12 1967, list 7.) OXAFLUMAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oxaflumazine under HS 29343090 and SITC 51578. As of Q4 2014, OXAFLUMAZINE remains the US FDA Preferred Term for this commodity. Oxaflumazine bears US NLM identifiers UMLS ID C0069710 and NCI Concept Code C90762. SMILES: S1C2C(N(CCCN3CCN(CC3)CCC3OCCCO3)C3C1CCCC3)CC(CC2)C(F)(F)F.
Same parent
Under 51332800 · 79Activities that produce or sell this
KBLI · 8Inherited from family 51330000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.